Back
Charles River Laboratories International Vs. Medpace Holdings Industry Stock Comparison
Buy
59
CRL
Charles River Laboratories International
Last Price:
233.00
Seasonality Move:
7.05%
Buy
70
MEDP
Medpace Holdings
Last Price:
398.73
Seasonality Move:
32.45%
Buy
59
Charles River Laboratories International (CRL)
is a Buy
Is Charles River Laboratories International a Buy, Sell or Hold?
- The current Charles River Laboratories International [CRL] share price is $232.82. The Score for CRL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- CRL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Medpace Holdings (MEDP)
is a Buy
Is Medpace Holdings a Buy, Sell or Hold?
- The current Medpace Holdings [MEDP] share price is $398.52. The Score for MEDP is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- MEDP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRL Stock Price Chart
What is Charles River Laboratories International's stock price today?
-
The Charles River Laboratories International share price today is $232.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRL is experiencing buying pressure, which is a positive indicator for future bullish movement.
MEDP Stock Price Chart
What is Medpace Holdings's stock price today?
-
The Medpace Holdings share price today is $398.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MEDP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.07 | Sell |
Relative Strength Index (14 RSI): | 45.44 | Sell |
Chaikin Money Flow: | 439319 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
MEDP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.56 | Buy |
Relative Strength Index (14 RSI): | 52.66 | Buy |
Chaikin Money Flow: | 108905 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
CRL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 232.47 | Buy |
20-day SMA: | 231.84 | Buy |
50-day SMA: | 248.6 | Sell |
200-day SMA: | 217.93 | Buy |
8-day EMA: | 231.57 | Buy |
20-day EMA: | 234.56 | Sell |
50-day EMA: | 239.47 | Sell |
200-day EMA: | 226.76 | Buy |
MEDP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 394.94 | Buy |
20-day SMA: | 391.64 | Buy |
50-day SMA: | 397.08 | Buy |
200-day SMA: | 312.52 | Buy |
8-day EMA: | 394.32 | Buy |
20-day EMA: | 393.88 | Buy |
50-day EMA: | 387.34 | Buy |
200-day EMA: | 325.07 | Buy |
Charles River Laboratories International Earnings Growth & CRL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.66 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.23 per share, and an increase next year of $1.43 per share.
Medpace Holdings Earnings Growth & MEDP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.72 per share, a decrease next quarter of $0.05 per share, an increase this year of $2.42 per share, and an increase next year of $1.97 per share.
Charles River Laboratories International Technical Analysis
May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Medpace Holdings Technical Analysis
May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |